<--- Back to Details
First PageDocument Content
Coagulation system / Warfarin / Prothrombin complex concentrate / Factor X / Anticoagulant / Vitamin K / Dabigatran / Rivaroxaban / Coagulation / Chemistry / Blood / Hematology
Date: 2014-09-10 16:37:01
Coagulation system
Warfarin
Prothrombin complex concentrate
Factor X
Anticoagulant
Vitamin K
Dabigatran
Rivaroxaban
Coagulation
Chemistry
Blood
Hematology

November[removed]THE MARYLAND POISON CENTER’S MONTHLY UPDATE. NEWS. ADVANCES. INFORMATION. Treatment of Warfarin Over-anticoagulation:

Add to Reading List

Source URL: mdpoison.com

Download Document from Source Website

File Size: 672,44 KB

Share Document on Facebook

Similar Documents

Center Information: Subcenter: Inland Northwest Blood Center Inland Northwest Blood Center 210 W. Cataldo Ave.

Center Information: Subcenter: Inland Northwest Blood Center Inland Northwest Blood Center 210 W. Cataldo Ave.

DocID: 1riKA - View Document

Microsoft Wordfile00

Microsoft Wordfile00

DocID: 1r9dZ - View Document

News Releases  Global Home | CSL Behring US | CSL Plasma | All CSL Behring Web Sites  

News Releases Global Home | CSL Behring US | CSL Plasma | All CSL Behring Web Sites  

DocID: 1qHpD - View Document

RECOTHROM, Thrombin topical (Recombinant) Package Insert

RECOTHROM, Thrombin topical (Recombinant) Package Insert

DocID: 1qv5K - View Document

Quester leads £3.1million investment in Haemostatix 23 January 2006 – Quester, a leading UK venture capital company, announced today that it has led a £3.1million investment in Haemostatix Ltd, a drug design and deve

Quester leads £3.1million investment in Haemostatix 23 January 2006 – Quester, a leading UK venture capital company, announced today that it has led a £3.1million investment in Haemostatix Ltd, a drug design and deve

DocID: 1qk7W - View Document